Modus Therapeutics Holding AB Share Price
Equities
MODTX
SE0015987904
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.968 SEK | -2.81% | -5.56% | -44.21% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 34.79M 381M 2.78B |
---|---|---|---|---|---|
Net income 2024 * | -27M -295M -2.16B | Net income 2025 * | -37M -405M -2.96B | EV / Sales 2024 * | - |
Net cash position 2024 * | 13M 142M 1.04B | Net cash position 2025 * | 47M 514M 3.76B | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.29
x | P/E ratio 2025 * |
-0.93
x | Employees | 2 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 10.5% |
1 day | -2.81% | ||
1 week | -5.56% | ||
Current month | -15.09% | ||
1 month | -12.79% | ||
3 months | -53.24% | ||
6 months | -49.97% | ||
Current year | -44.21% |
Managers | Title | Age | Since |
---|---|---|---|
John Öhd
CEO | Chief Executive Officer | 53 | 31/12/17 |
Claes Lindblad
DFI | Director of Finance/CFO | 57 | 14/03/21 |
Ellen Donnelly
BRD | Director/Board Member | 50 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Viktor Drvota
CHM | Chairman | 59 | 31/12/15 |
Director/Board Member | 65 | 31/12/13 | |
Ellen Donnelly
BRD | Director/Board Member | 50 | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 0.968 | -2.81% | 2,852 |
25/04/24 | 0.996 | -3.30% | 18,344 |
24/04/24 | 1.03 | +3.00% | 11,042 |
23/04/24 | 1 | -2.44% | 14,100 |
22/04/24 | 1.025 | 0.00% | 329 |
Delayed Quote Nasdaq Stockholm, April 26, 2024 at 04:19 pm
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-44.21% | 3.17M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- MODTX Stock